NBS1 (NBN)

NBS1 (NBN)

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4ea;">NBS1 (NBN)</th></tr>
<tr><td><b>Full Name</b></td><td>Nijmegen Breakage Syndrome 1 / Nibrin</td></tr>
<tr><td><b>Symbol</b></td><td>NBS1 (official), NBN (alias)</td></tr>
<tr><td><b>Chromosomal Location</b></td><td>8q21.3</td></tr>
<tr><td><b>NCBI Gene ID</b></td><td>[4683](https://www.ncbi.nlm.nih.gov/gene/4683)</td></tr>
<tr><td><b>OMIM</b></td><td>[607455](https://www.omim.org/entry/607455)</td></tr>
<tr><td><b>Ensembl ID</b></td><td>ENSG00000104320</td></tr>
<tr><td><b>UniProt ID</b></td><td>[O60347](https://www.uniprot.org/uniprot/O60347)</td></tr>
<tr><td><b>Associated Diseases</b></td><td>[Nijmegen Breakage Syndrome](/diseases/nijmegen-breakage-syndrome), [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), Cancer</td></tr>
</table>
</div>

Pathway / Interaction Diagram

Overview

NBS1 (NBN)

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4ea;">NBS1 (NBN)</th></tr>
<tr><td><b>Full Name</b></td><td>Nijmegen Breakage Syndrome 1 / Nibrin</td></tr>
<tr><td><b>Symbol</b></td><td>NBS1 (official), NBN (alias)</td></tr>
<tr><td><b>Chromosomal Location</b></td><td>8q21.3</td></tr>
<tr><td><b>NCBI Gene ID</b></td><td>[4683](https://www.ncbi.nlm.nih.gov/gene/4683)</td></tr>
<tr><td><b>OMIM</b></td><td>[607455](https://www.omim.org/entry/607455)</td></tr>
<tr><td><b>Ensembl ID</b></td><td>ENSG00000104320</td></tr>
<tr><td><b>UniProt ID</b></td><td>[O60347](https://www.uniprot.org/uniprot/O60347)</td></tr>
<tr><td><b>Associated Diseases</b></td><td>[Nijmegen Breakage Syndrome](/diseases/nijmegen-breakage-syndrome), [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), Cancer</td></tr>
</table>
</div>

Pathway / Interaction Diagram

Overview

NBS1 (Nijmegen Breakage Syndrome 1), also known as nibrin, is a critical DNA repair protein that plays a central role in maintaining genomic stability. As a core component of the [MRN complex](/mechanisms/dna-repair-neurodegeneration) (MRE11-RAD50-NBS1), NBS1 is essential for detecting, signaling, and repairing DNA double-strand breaks (DSBs)—one of the most cytotoxic forms of DNA damage[@mrkarc_2018]. Mutations in NBS1 cause Nijmegen Breakage Syndrome (NBS), a rare autosomal recessive disorder characterized by microcephaly, growth retardation, immunodeficiency, and markedly increased cancer risk[@nbs1_1998].

Beyond its well-established role in cancer predisposition, emerging research has revealed that NBS1 dysfunction contributes to the pathogenesis of major neurodegenerative diseases, including [Alzheimer's disease (AD)](/diseases/alzheimers-disease) and [Parkinson's disease (PD)](/diseases/parkinsons-disease)[@pasamonti_2019]. The inability to properly repair DNA damage accumulates in post-mitotic neurons over time, leading to genomic instability, mitochondrial dysfunction, and ultimately neuronal death. This page provides a comprehensive overview of NBS1's molecular function, its role in the DNA damage response (DDR), and its implications for neurodegenerative disease pathogenesis and therapeutic targeting.

Molecular Function and Structure

Protein Structure

NBS1 is a 754-amino acid protein encoded by the NBS1 gene located on chromosome 8q21.3. The protein contains several functional domains that mediate its interactions within the MRN complex and with downstream signaling proteins:

• Forkhead-associated (FHA) domain (residues 110-190): Mediates protein-protein interactions with phosphorylated targets
• BRCT domain (residues 680-750): Involved in DNA damage signaling and recruitment of additional repair proteins

Role in the MRN Complex

NBS1 functions as part of the heterotrimeric MRN complex, which consists of:

• MRE11 (meiotic recombination 11 homolog): A nuclease that processes DNA ends
• RAD50: A protein that bridges DNA ends and maintains DNA end proximity
• NBS1: The signaling and scaffolding component

The NBS1 protein undergoes phosphorylation by ATM in response to DNA damage, a modification critical for activating the intra-S phase checkpoint and facilitating proper DNA repair[@pasamonti_2019].

DNA Damage Response in Neurons

Neuronal Vulnerability to DNA Damage

[Neurons](/entities/neurons) are particularly vulnerable to DNA damage due to their post-mitotic nature and high metabolic activity. Unlike dividing cells, neurons cannot dilute out accumulated DNA damage through cell division, making DNA repair pathways especially critical for neuronal survival[@williams_2018]. The brain consumes approximately 20% of the body's oxygen despite representing only 2% of body weight, generating substantial reactive oxygen species (ROS) that can cause oxidative DNA damage.

Key sources of DNA damage in neurons include:

• Oxidative stress: ROS-induced base modifications and single-strand breaks
• Endogenous metabolic byproducts: Spontaneous depurination, deamination reactions
• Transcriptional stress: RNA polymerase stalling and transcription-coupled repair deficits
• Mitochondrial dysfunction: Mitochondrial DNA damage and impaired nuclear-mitochondrial communication

The DNA Damage Response in Aging and Neurodegeneration

The DNA damage response becomes progressively impaired during aging, and this decline is a central feature of neurodegenerative diseases[@kumar_2021]. Several lines of evidence support a role for NBS1 and the MRN complex in neurodegeneration:

NBS1 in Alzheimer's Disease

Evidence from Model Systems

Multiple studies have demonstrated that NBS1 deficiency exacerbates [Alzheimer's disease](/diseases/alzheimers-disease) pathology in cellular and animal models. Key findings include:

• Accelerated amyloid pathology: NBS1 deficiency in neurons leads to increased amyloid-beta production and reduced clearance[@andersen_2022]
• Tau hyperphosphorylation: DNA repair deficits activate stress pathways that promote tau pathology
• Synaptic dysfunction: NBS1-deficient neurons show impaired synaptic plasticity and dendritic spine loss

Proposed Mechanisms

Several mechanisms have been proposed to explain how NBS1 dysfunction contributes to AD pathogenesis:

| Mechanism | Description | Evidence |
|-----------|-------------|----------|
| DNA repair failure | Accumulated DSBs trigger neuronal apoptosis | Elevated γ-H2AX in AD brains |
| Telomere dysfunction | Short telomeres activate DNA damage response | Accelerated telomere shortening in AD |
| Mitochondrial dysfunction | Impaired mitochondrial DNA repair | Reduced mitochondrial NBS1 in AD |
| Transcriptional dysregulation | DNA damage blocks gene expression | Altered transcriptomes in NBS1-deficient neurons |

Genetic Associations

Recent genome-wide association studies (GWAS) have identified NBS1 variants that modify Alzheimer's disease risk[@liu_2020][@gupta_2024]. While these variants have small effect sizes, they provide evidence that DNA repair pathways influence AD susceptibility. Individuals carrying certain NBS1 haplotypes show:

• Earlier age of onset
• Faster disease progression
• Increased burden of age-related DNA damage

NBS1 in Parkinson's Disease

Mitochondrial DNA Damage

[Parkinson's disease](/diseases/parkinsons-disease) is particularly associated with mitochondrial dysfunction, and NBS1 plays a role in maintaining mitochondrial DNA (mtDNA) integrity[@karan_2019]. The MRN complex is involved in:

• MtDNA repair: The MRN complex localizes to mitochondria and participates in mtDNA DSB repair
• Mitophagy regulation: NBS1 interacts with PINK1/Parkin mitophagy pathway components
• Mitochondrial dynamics: DNA damage signaling influences mitochondrial fission and fusion

Genetic Association Studies

Several studies have investigated the relationship between NBS1 polymorphisms and PD risk:

• NBS1 variants have been associated with increased PD susceptibility in some populations[@zhang_2021]
• Haplotypes affecting NBS1 expression modify age of onset
• Functional variants that reduce NBS1 expression show correlation with disease severity

NBS1 in Other Neurodegenerative Conditions

Ataxia-Telangiectasia-Like Disorder

While mutations in NBS1 cause NBS, heterozygous carriers show increased susceptibility to neurodegenerative conditions. The related ataxia-telangiectasia-like disorder (ATLD), caused by MRE11 mutations, presents with similar neurological phenotypes, highlighting the importance of the MRN complex in neuronal survival[@shibata_2014].

Cognitive Impairment in NBS Patients

Individuals with Nijmegen Breakage Syndrome demonstrate progressive cognitive impairment in addition to their primary symptoms[@bartha_2018]. This observation provides direct evidence that NBS1 dysfunction is pathogenic in the human brain:

• Learning disabilities and intellectual disability are common
• Progressive decline in executive function
• Increased risk of early-onset dementia

Amyotrophic Lateral Sclerosis (ALS)

Emerging evidence suggests that DNA repair deficits contribute to [ALS](/diseases/amyotrophic-lateral-sclerosis) pathogenesis. NBS1 and the MRN complex may be involved in:

• Repair of oxidative DNA damage in motor neurons
• Response to glutamate excitotoxicity
• Regulation of neuroinflammation

The MRN Complex Beyond NBS1

MRE11 - The Nuclease Component

MRE11 (Meiotic Recombination 11) is the nuclease component of the MRN complex, possessing both endonuclease and 3'→5' exonuclease activity. MRE11 processes DNA ends during repair and initiates the DNA damage signaling cascade. Mutations in MRE11 cause ATLD, which shares neurological features with NBS, including cerebellar ataxia and cognitive decline.

RAD50 - The Scaffold Protein

RAD50 serves as the structural scaffold of the MRN complex, holding MRE11 and NBS1 together and bridging DNA ends. RAD50 is essential for telomere maintenance and meiotic recombination. While RAD50 mutations are rare, polymorphisms in the gene have been associated with increased cancer risk.

The Complete DNA Damage Response Cascade

The MRN complex initiates a signaling cascade that involves multiple kinases and effector proteins:

This cascade is essential for proper DNA repair choice—homologous recombination (HR) vs. non-homologous end joining (NHEJ)—and its dysregulation contributes to both cancer and neurodegeneration.

NBS1 and Tau Pathology

DNA Damage-Induced Tau Phosphorylation

Recent research has revealed a direct connection between DNA damage response activation and [tau protein](/proteins/tau) pathology, a hallmark of Alzheimer's disease. Key mechanisms include:

• Checkpoint kinase activation: DNA damage activates checkpoint kinases Chk1 and Chk2, which can phosphorylate tau at disease-relevant sites
• GSK3β activation: ATM signaling can activate glycogen synthase kinase 3 beta (GSK3β), a major tau kinase
• PP2A inhibition: DNA damage response proteins can inhibit protein phosphatase 2A (PP2A), reducing tau dephosphorylation

Therapeutic Implications for Tauopathies

The link between NBS1 dysfunction and tau pathology suggests several therapeutic approaches:

• DNA damage response modulators: Small molecules that normalize DDR signaling
• Tau kinase inhibitors: Target downstream effectors of DNA damage
• Gene therapy: Restore proper NBS1 expression in neurons

NBS1 and Neuroinflammation

DNA Damage Inflammatory Signaling

The DNA damage response intersects with neuroinflammation through multiple pathways:

• cGAS-STING pathway: Cytosolic DNA sensing activates innate immune responses
• ATM-NF-κB signaling: DNA damage activates nuclear factor kappa B
• Inflammasome activation: DNA damage can trigger NLRP3 inflammasome assembly

Microglial NBS1 Function

Microglial cells, the brain's resident immune cells, rely on NBS1 for:

• Responding to pathogen DNA and cellular debris
• Maintaining inflammatory homeostasis
• Clearing amyloid plaques and protein aggregates

NBS1 and Synaptic Function

DNA Repair at Synapses

Synaptic activity generates significant DNA damage, particularly in regions of high transcriptional activity. NBS1 is localized to synapses and contributes to:

• Activity-induced DNA repair
• Synaptic plasticity genes expression
• Dendritic spine maintenance

Consequences of Synaptic DNA Repair Failure

When NBS1 function is impaired, synapses are particularly vulnerable:

• Reduced dendritic spine density
• Impaired long-term potentiation (LTP)
• Deficient learning and memory formation
• Accelerated synaptic degeneration

Biomarkers of NBS1 Dysfunction

Blood-Based Markers

Several blood-based biomarkers can indicate NBS1 dysfunction:

• γ-H2AX in peripheral blood mononuclear cells: Reflects systemic DNA damage burden
• NBS1 protein levels: Reduced levels indicate impaired function
• p53 activation status: Elevated p53 suggests DNA damage response activation

CSF Markers

Cerebrospinal fluid biomarkers include:

• Neurofilament light chain (NfL): Indicates neurodegeneration
• Tau and phospho-tau: Reflects neuronal injury
• DNA damage markers: Including γ-H2AX and 53BP1

Imaging Markers

Advanced imaging can reveal NBS1-related pathology:

• Magnetic resonance spectroscopy: Detects metabolic abnormalities
• PET imaging: Amyloid and tau burden
• Diffusion tensor imaging: White matter integrity

Therapeutic Implications

Targeting DNA Repair for Neurodegeneration

The recognition that DNA repair deficits contribute to neurodegenerative disease has opened new therapeutic avenues[@fouquerel_2016]:

Small molecule approaches:

• ATM inhibitors: Sensitize neurons to DNA damage-induced death (for cancer, not neurodegeneration)
• PARP inhibitors: Enhance DNA repair capacity
• Antioxidants: Reduce oxidative DNA damage burden

• NBS1 overexpression: Enhance DNA repair capacity in neurons
• MRN complex stabilization: Promote proper complex assembly and function

• Poly(ADP-ribose) polymerase (PARP) activators
• Nucleotide excision repair enhancers
• Base excision repair cofactors

Challenges and Considerations

Therapeutic targeting of NBS1 and the DNA damage response faces significant challenges:

Emerging Therapeutic Strategies

Pharmacological Approaches

| Drug Class | Mechanism | Development Stage | Notes |
|-----------|-----------|-------------------|-------|
| PARP inhibitors | Enhance base excision repair | FDA approved for cancer | Being explored for neurodegeneration |
| ATM activators | Promote DDR signaling | Preclinical | May enhance repair capacity |
| NBS1 stabilizers | Promote complex assembly | Discovery | Novel target |
| Antioxidants | Reduce oxidative damage | Clinical trials | Limited efficacy alone |

Gene Therapy Vectors

Viral vector delivery of NBS1 is being explored:

• AAV vectors: Adeno-associated viruses for neuronal transduction
• Non-viral approaches: Lipid nanoparticles for brain delivery
• CRISPR base editors: Precision editing of NBS1 variants

Combination Therapies

Given the complex nature of neurodegeneration, NBS1-targeted approaches may be combined with:

• Amyloid-lowering therapies
• Tau-targeting treatments
• Neuroinflammation modulators
• Mitochondrial protectants

Expression Patterns

Brain Expression

NBS1 is ubiquitously expressed throughout the body, including high expression in brain tissue. Within the brain, NBS1 is expressed in:

• Neurons: Especially in cortical and hippocampal regions
• Astrocytes: Supporting cells that also experience DNA damage
• Oligodendrocytes: Myelin-producing cells
• Microglial cells: Brain immune cells

Regulation

NBS1 expression is regulated by:

• p53: Tumor suppressor that induces NBS1 expression in response to DNA damage
• ATM: Phosphorylates and stabilizes NBS1 protein
• FOXO transcription factors: Regulate NBS1 under oxidative stress
• SIRT1: Deacetylase that modulates NBS1 activity

Cross-Links

• [DNA Repair in Neurodegeneration](/mechanisms/dna-repair-neurodegeneration)
• [Genomic Stability Mechanisms](/mechanisms/genomic-stability)
• [Mitochondrial Dysfunction in AD](/mechanisms/mitochondrial-dysfunction-alzheimers)
• [Oxidative Stress in Neurodegeneration](/mechanisms/oxidative-stress-neurodegeneration)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Genes Index](/genes)

See Also

• [Genes Section](/genes)
• [DNA Repair Mechanisms](/mechanisms/dna-repair-neurodegeneration)
• [MRN Complex Research](/mechanisms/mrn-complex)
• [ATM Gene](/genes/atm-gene)

External Links

• [NCBI Gene: NBS1 (4683)](https://www.ncbi.nlm.nih.gov/gene/4683)
• [OMIM: NBS1](https://www.omim.org/entry/607455)
• [Ensembl: ENSG00000104320](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000104320)
• [UniProt: O60347](https://www.uniprot.org/uniprot/O60347)
• [PubMed: NBS1 Research](https://pubmed.ncbi.nlm.nih.gov/?term=NBS1+neurodegeneration)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving NBS1 (NBN) discovered through SciDEX knowledge graph analysis: